Clinical trial
Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary…
NCT00169845 · Laval University, Other · Completed
Key facts
| NCT number | NCT00169845 |
|---|---|
| Title | Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients |
| Official title | Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients |
| Lead sponsor | Laval University, Other |
| Collaborators | Canadian Cancer Trials Group National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Dietary Supplement |
| Interventions | Alpha-Tocopherol and Beta-Carotene, Placebo |
| Enrollment | 540 |
| Start date | Oct 1, 1994 |
| Primary completion | Jun 1, 2003 |
| Completion | Mar 1, 2018 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 14, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: